Optimising business key for pharma in downturn, says CourtSquareGroup

By Gareth Macdonald

- Last updated on GMT

Related tags: Pharmacology

US strategic consultants CourtSquareGroup say that while optimisation of operations is key for the drug industry, companies risk losing the business knowledge required to undertake such action in the scramble to cut costs in the global downturn.

Keith Parent and Andy Sontag from CourtSquare told in-PharmaTechnologist about the emerging trend among pharmaceutical companies to seek specialist business process optimisation (BPO) expertise.

As pharmaceutical manufacturing processes become more complex, identifying critical steps and where improvements can be made is becoming increasingly complex.

Andy and Keith explain that this complexity is driving demand for BPO and predict that the market will continue to expand for the foreseeable future.

Related topics: Regulatory & Safety, Processing equipment

Related products

The battle of performance in pharma production

The battle of performance in pharma production

Telstar Life Science Solutions | 26-Mar-2019 | Case Study

Telstar case study. Discover how a versatile freeze-dryer automatic loading & unloading systemDiscover how a versatile freeze-dryer automatic loading...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Steridose

Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Related suppliers